Pfizer’s Lyme disease vaccine trial hampered by lack of casesnews2026-03-23T10:45:45+00:00March 23rd, 2026|Endpoints News|
Top HHS official tamps down expectations on scope of TrumpRxnews2026-03-20T16:45:24+00:00March 20th, 2026|Endpoints News|
UK’s NICE revisits Lilly, Eisai Alzheimer’s drugs under new pricing thresholdnews2026-03-20T14:51:59+00:00March 20th, 2026|Endpoints News|
Novo Holdings CEO discusses investments, geopolitics and Chinanews2026-03-20T12:00:34+00:00March 20th, 2026|Endpoints News|
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovationnews2026-03-20T11:40:21+00:00March 20th, 2026|Endpoints News|
Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refutednews2026-03-20T00:26:49+00:00March 20th, 2026|Endpoints News|
Novo wins FDA approval for high-dose Wegovy under commissioner’s vouchernews2026-03-19T18:06:03+00:00March 19th, 2026|Endpoints News|
CSL says its hemophilia B gene therapy is out of stocknews2026-03-19T16:33:06+00:00March 19th, 2026|Endpoints News|
Collegium is acquiring Corium’s approved ADHD drug for $650Mnews2026-03-19T14:55:37+00:00March 19th, 2026|Endpoints News|
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 winnews2026-03-19T14:24:11+00:00March 19th, 2026|Endpoints News|
